ArticlePathology oncology research : POR2022

Overexpression of Dehydrogenase/Reductase 9 Predicts Poor Response to Concurrent Chemoradiotherapy and Poor Prognosis in Rectal Cancer Patients.

Tzu-Ju Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.